F
$ Value
$18K
Shares
1,653
Price
$11
Filed
May 30
Insider
Name
Pulik Richard
Title
CFO
CIK
0001885841
Roles
Officer
Transaction Details
Transaction Date
2025-05-28
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
400,559
Footnotes
Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
Filing Info
Pulik Richard's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-20 | ROIV | A | $0 |
| 2026-04-20 | ROIV | A | $0 |
| 2026-03-20 | ROIV | F | $43K |
| 2025-08-20 | ROIV | F | $14K |
| 2025-07-28 | ROIV | F | $22K |
| 2025-06-28 | ROIV | F | $19K |
| 2025-06-20 | ROIV | F | $17K |
| 2025-05-28 | ROIV | F | $18K |
| 2025-05-20 | ROIV | F | $38K |
| 2025-04-28 | ROIV | F | $18K |
Other Insiders at ROIV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MOMTAZEE JAMES C | — | — | 2026-04-17 |
| Fitzgerald Meghan | — | $1.9M | 2026-03-26 |
| Oren Ilan | — | — | 2026-04-17 |
|
Torti Frank
President and Vant Chair
|
— | — | 2026-03-31 |
|
Sukhatme Mayukh
President & CIO
|
— | — | 2026-03-31 |
|
Gline Matthew
CEO
|
— | $8.4M | 2026-04-16 |
|
Venker Eric
President & Immunovant CEO
|
— | $5.9M | 2026-04-20 |
| Epperly Melissa B, | — | — | 2026-04-17 |
|
Pulik Richard
CFO
|
— | — | 2026-04-20 |
|
Humes Jennifer
Chief Accounting Officer
|
— | $384K | 2026-04-20 |